The battle for the upstream industry chain of traditional Chinese medicine accelerates China Resources Sanjiu's plan to enter the Kunming Pharmaceutical Group at a premium of 2.9 billion yuan 21 Economic Net

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

000681 000999 002786 300078 300170 300294 300494 300713 Boya Bio-Pharmaceutical Group China Resources Sanjiu Medical & Pharmaceutical China Shipbuilding Industry Group Power Citic Securities Dongguan Huali Industries Fujian Funeng Hand Enterprise Solutions Hangzhou Century Hubei Century Network Technology Jiangzhong Pharmaceutical Kpc Pharmaceuticals Shenzhen Silver Basis Technology Shenzhenrease Technology Visual China Group Xinjiang Sayram Modern Agriculture Fire Restructuring, Recapitalisation Shareholder Management Strategy, Marketing Annual, Special Corporate Meeting Annual Report Board Of Directors Patent, Copyright, Trademark Research, Development Health, Beauty Product Pharmaceutical Retail Energy, Resource Electricity Production, Distribution Financial, Business Service Manufacturing, Engineering Credit, Debt Market, Exchange Diseases, Conditions Hospital Small, Medium Enterprise Series Economy, Business, Finance Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » The battle for the upstream industry chain of traditional Chinese medicine accelerates China Resources Sanjiu's plan to enter the Kunming Pharmaceutical Group at a premium of 2.9 billion yuan 21 Economic Net